High materiality7/10
Incyte (INCY) PT Raised to $127 at UBS, Neutral Rating Maintained
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raises INCY target to $127; Neutral rating maintained; current price 113.03.
- UBS raises INCY PT to $127; Neutral rating maintained.
Key facts
- 01
Target: $127
- 02
Posted price: $113.03
- 03
Analyst firm: UBS
- 04
Analyst: Ashwani Verma
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.